Eli Lilly

Humalog Mix 50/50 insulin lispro protamine and insulin lispro injectable suspension 100 units/mL 3ml KwikPen.

Humalog KwikPen 200 units/mL 3ml pen for insulin lispro injection therapy.

Humalog Tempo Pen 100 units/mL 3ml connected pen device for insulin lispro injection therapy.

Humalog KwikPen Junior 100 units/mL 5-pen pack.

Rapid-acting mealtime insulin available in a prefilled lightweight pen or as a vial and syringe for blood sugar control.

Insulin lispro pre-filled pen device in various mix formulations.

Prefilled mealtime insulin pen holding double the insulin concentration of U-100 pens in the same familiar design.

Humalog 100 units/mL 3ml vial (alternate NDC) for insulin lispro injection therapy.

Humalog Mix75/25 100 units/mL 10mL vial.

Humalog 100 units/mL insulin lispro cartridges.

Insulin lispro cartridges in various mix formulations.

Vial formulation of Humalog U-100 mealtime insulin for use with syringes or insulin pumps.

25% insulin lispro injection, 75% insulin lispro protamine suspension.

Intermediate-acting insulin human isophane suspension to cover blood sugar increases between meals and during the night.

Humulin N KwikPen (insulin isophane human) 100 units/mL, 3 mL, 5-pack.

Humulin N 100 units/mL 10mL vial.

Basaglar (insulin glargine [rDNA origin] injection) is a prescription insulin therapy provided by Lilly Medical Canada for Canadian healthcare professionals.

Human insulin isophane suspension and human insulin injection.

Humulin 70/30 KwikPen 5-pen pack.

Humulin 70/30 100 units/mL 10mL vial.

Humulin R U-500 is a concentrated insulin used to control high blood sugar in adults and children with diabetes mellitus who need more than 200 units of insulin in a day.

Humulin R KwikPen 500 units/mL 2-pen pack.

Short-acting insulin human injection to cover blood sugar increases from meals eaten within 30 minutes.

Biosynthetic human insulin vials.

Biosynthetic human insulin cartridges.

Insulin Lispro KwikPen 100 units/mL 5-pen pack.

A disposable prefilled pen designed to deliver Humulin R U-500 concentrated insulin, holding 1500 units per pen and dosing up to 300 units at a time in 5-unit increments.

Traditional vial and dedicated syringe delivery option for administering Humulin R U-500 concentrated insulin.

An insulin delivery pen modified to work with the Tempo Smart Button, functioning similarly to the KwikPen.

A prefilled insulin pen used to administer Lyumjev mealtime insulin.

Lyumjev injection 100 units/mL 10mL vial.

Insulin lispro-aabc injection for glycemic control in diabetes.

Omvoh (mirikizumab-mrkz) 300MG/15ML Vial presentation for administration.

IL-23 inhibitor IBD drug containing Mirikizumab 100 mg.

EBGLYSS (lebrikizumab-lbkz) 250MG/2ML Prefilled Syringe.

Oncology monoclonal antibody containing Ramucirumab.

CDK4/6 inhibitor breast cancer drug and breast cancer endocrine therapy containing Abemaciclib 100 mg.

Citrate-free formulation of ixekizumab for immunology and dermatology.

Jaypirca (pirtobrutinib) 100 MG tablet supplied in a pack size of 60.

Cialis (tadalafil) tablets in various strengths packaged in special child-resistant packaging complying with the Poison Prevention Packaging Act.

A multi-dose pen that holds four doses of Zepbound (tirzepatide) medicine, one for each week of the month, designed for weight management in adults with obesity.

Diabetes incretin medicine and GLP-1/GIP dual agonist containing Tirzepatide 12.5 mg.

Humalog Mix 75/25 KwikPen 5-pen pack.

Foundayo (orforglipron) tablets in various strengths packaged in special child-resistant packaging complying with the Poison Prevention Packaging Act.

Insulin glargine-aglr injection for diabetes management.

somatropin (rDNA origin) for injection

Chemotherapy prescription medicine for oncology.

imlunestrant tablets

Baricitinib tablets manufactured by Eli Lilly for healthcare professionals.

Insulin injection 500 units/mL, human biosynthetic.

florbetapir F18 injection

Prescription medication containing Selpercatinib 40 mg.

Empagliflozin tablets for type 2 diabetes and related conditions.

flortaucipir F18 injection

gemcitabine for injection

necitumumab injection

尿に糖を排出させることでインスリンと関係なく血糖を下げる経口薬。

Large molecule candidate for obesity treatment.

Insulin efsitora alfa-gobe injection therapy.

Humalog insulin therapies for diabetes management.

Large molecule multi-receptor agonist candidate for obesity, diabetes, and related metabolic conditions.

Large molecule candidate for obesity and sleep apnea.

インクレチンを分解する酵素の働きを抑えてインクレチンを長持ちさせ、食後の高血糖を改善する経口薬。

消化管からの糖の吸収を遅らせることで食後の血糖上昇を抑える経口薬。

糖新生を抑え、消化管からの糖の吸収抑制や筋肉でのインスリン作用を強めて血糖を下げる経口薬。

lasmiditan tablets CV

Insulin delivery pen device

服用してから効果が早くあらわれるため、食後の高血糖の改善に適した経口薬。

すい臓からのインスリン分泌を増やし血糖を下げる経口薬。少なめの量を他の薬と併用して使うことが多くなっています。

Donanemab for injection, an anti-amyloid Alzheimer's medicine.

teriparatide injection

インスリン抵抗性を改善することでインスリンの働きをよくして血糖を下げる経口薬。

Large molecule biologic for allergic rhinitis and chronic rhinosinusitis.

fluoxetine capsules

COVID-19 medication

Large molecule pipeline candidate and therapy for cardiometabolic conditions.

ERBITUX (cetuximab) is a recombinant, human/mouse chimeric monoclonal antibody that binds specifically to the extracellular domain of the human epidermal growth factor receptor (EGFR) with high affinity.

atomoxetine capsules

Large molecule pipeline candidate for diabetes therapy.

Large molecule pipeline candidate for neuroscience and other indications.

Cymbalta (duloxetine) delayed release capsules in various strengths packaged in special child-resistant packaging complying with the Poison Prevention Packaging Act.

Selpercatinib in capsule form for cancer treatment.

prasugrel tablets

Large molecule candidate for inflammatory disorders.

Combination large molecule candidate for inflammatory bowel diseases.

Adcirca (tadalafil) tablets packaged in special child-resistant packaging complying with the Poison Prevention Packaging Act.

Large molecule candidate for hidradenitis suppurativa and ulcerative colitis.

Large molecule candidate for early Alzheimer's disease.

Small molecule pipeline candidate for cancer therapies including CLL and MCL.

Evista (raloxifene HCl) tablets packaged in special child-resistant packaging complying with the Poison Prevention Packaging Act.

Galcanezumab injection for Canadian healthcare professionals to search for answers and medical information.

Small molecule pipeline candidate for cardiometabolic health and diabetes.

Large molecule pipeline candidate for shingles.

Small molecule candidate targeting KRAS G12C-mutant NSCLC.

Small molecule candidate for central disorders of hypersomnolence.

Large molecule gene therapy candidate for wet AMD.

Small molecule pipeline candidate for pain management.

Large molecule gene therapy candidate for AIPL1-related IRD.